{"entity":{"type":"insider","cik":"0001855608","url":"/insider/0001855608","json_url":"/insider/0001855608.json","name":"Valantine Hannah","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":19,"first":"2022-01-03","last":"2026-07-17","span_basis":"filed_date"},"name_variants":[{"name":"Valantine Hannah","source":"filing","n_filings":19,"first_seen":"2022-01-03","last_seen":"2026-07-17"}],"transactions":[{"id":5900341,"accession":"0001855608-26-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001855608-26-000004","line_url":"/filing/0001855608-26-000004","is_derivative":false,"issuer_cik":"0001217234","issuer_name":"CareDx, Inc.","issuer_ticker":"CDNA","issuer_name_source":null,"issuer_url":"/issuer/0001217234","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28779.0,"shares_display":"28,779","price_per_share":36.1459090135168,"price_display":"36.15","price_state":"stated","total_value":1040243.1155,"total_display":"1,040,243.12","total_whole":"1,040,243","shares_owned_after":36786.0,"shares_owned_after_display":"36,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-16","filed_date":"2026-07-17","scope":"insider","n_lines":2},{"id":6166501,"accession":"0001470831-26-000635","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001470831-26-000635","line_url":"/filing/0001470831-26-000635#line-4","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2196.0,"shares_display":"2,196","price_per_share":68.57,"price_display":"68.57","price_state":"stated","total_value":150579.72,"total_display":"150,579.72","total_whole":"150,580","shares_owned_after":9259.0,"shares_owned_after_display":"9,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-24","scope":"insider"},{"id":6166498,"accession":"0001470831-26-000635","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001470831-26-000635","line_url":"/filing/0001470831-26-000635#line-3","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2808.0,"shares_display":"2,808","price_per_share":68.0,"price_display":"68.00","price_state":"stated","total_value":190944.0,"total_display":"190,944.00","total_whole":"190,944","shares_owned_after":11455.0,"shares_owned_after_display":"11,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":5792213,"accession":"0001855608-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001855608-26-000003","line_url":"/filing/0001855608-26-000003#line-2","is_derivative":false,"issuer_cik":"0001217234","issuer_name":"CareDx, Inc.","issuer_ticker":"CDNA","issuer_name_source":null,"issuer_url":"/issuer/0001217234","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12103.0,"shares_display":"12,103","price_per_share":23.1123,"price_display":"23.11","price_state":"stated","total_value":279728.1669,"total_display":"279,728.17","total_whole":"279,728","shares_owned_after":36686.0,"shares_owned_after_display":"36,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-16","scope":"insider"},{"id":6129765,"accession":"0001470831-26-000260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-26-000260","line_url":"/filing/0001470831-26-000260#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8671.0,"shares_display":"8,671","price_per_share":72.0,"price_display":"72.00","price_state":"stated","total_value":624312.0,"total_display":"624,312.00","total_whole":"624,312","shares_owned_after":7465.0,"shares_owned_after_display":"7,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-12","scope":"insider"},{"id":6038279,"accession":"0001470831-26-000236","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001470831-26-000236","line_url":"/filing/0001470831-26-000236","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25484.0,"shares_display":"25,484","price_per_share":67.4062486736776,"price_display":"67.41","price_state":"stated","total_value":1717780.8412,"total_display":"1,717,780.84","total_whole":"1,717,781","shares_owned_after":18365.0,"shares_owned_after_display":"18,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-03","scope":"insider","n_lines":2},{"id":5212845,"accession":"0001470831-25-000317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-25-000317","line_url":"/filing/0001470831-25-000317#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25484.0,"shares_display":"25,484","price_per_share":66.07,"price_display":"66.07","price_state":"stated","total_value":1683727.88,"total_display":"1,683,727.88","total_whole":"1,683,728","shares_owned_after":7465.0,"shares_owned_after_display":"7,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":4496947,"accession":"0000950170-25-091762","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-091762","line_url":"/filing/0000950170-25-091762","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4707.0,"shares_display":"4,707","price_per_share":44.046581070745695,"price_display":"44.05","price_state":"stated","total_value":207327.2571,"total_display":"207,327.26","total_whole":"207,327","shares_owned_after":398.0,"shares_owned_after_display":"398","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-26","filed_date":"2025-06-30","scope":"insider","n_lines":4},{"id":4236482,"accession":"0000950170-25-089022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-089022","line_url":"/filing/0000950170-25-089022#line-1","is_derivative":false,"issuer_cik":"0001217234","issuer_name":"CareDx, Inc.","issuer_ticker":"CDNA","issuer_name_source":null,"issuer_url":"/issuer/0001217234","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10570.0,"shares_display":"10,570","price_per_share":19.1642,"price_display":"19.16","price_state":"stated","total_value":202565.594,"total_display":"202,565.59","total_whole":"202,566","shares_owned_after":38994.0,"shares_owned_after_display":"38,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-18","filed_date":"2025-06-23","scope":"insider"},{"id":4792391,"accession":"0000950170-25-084914","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-084914","line_url":"/filing/0000950170-25-084914#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4292.0,"shares_display":"4,292","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":171680.0,"total_display":"171,680.00","total_whole":"171,680","shares_owned_after":1764.0,"shares_owned_after_display":"1,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-11","scope":"insider"},{"id":4495242,"accession":"0000950170-25-036420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-036420","line_url":"/filing/0000950170-25-036420#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12875.0,"shares_display":"12,875","price_per_share":32.5825,"price_display":"32.58","price_state":"stated","total_value":419499.6875,"total_display":"419,499.69","total_whole":"419,500","shares_owned_after":1764.0,"shares_owned_after_display":"1,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-10","scope":"insider"},{"id":3213175,"accession":"0000950170-24-017081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-017081","line_url":"/filing/0000950170-24-017081#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2915.0,"shares_display":"2,915","price_per_share":37.75,"price_display":"37.75","price_state":"stated","total_value":110041.25,"total_display":"110,041.25","total_whole":"110,041","shares_owned_after":1764.0,"shares_owned_after_display":"1,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-20","scope":"insider"},{"id":2892269,"accession":"0000950170-24-005380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-005380","line_url":"/filing/0000950170-24-005380#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2915.0,"shares_display":"2,915","price_per_share":37.97,"price_display":"37.97","price_state":"stated","total_value":110682.55,"total_display":"110,682.55","total_whole":"110,683","shares_owned_after":1764.0,"shares_owned_after_display":"1,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":8727586,"accession":"0001209191-23-059101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-059101","line_url":"/filing/0001209191-23-059101#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2915.0,"shares_display":"2,915","price_per_share":36.12,"price_display":"36.12","price_state":"stated","total_value":105289.8,"total_display":"105,289.80","total_whole":"105,290","shares_owned_after":1764.0,"shares_owned_after_display":"1,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-19","scope":"insider"},{"id":8255549,"accession":"0001209191-23-055717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-055717","line_url":"/filing/0001209191-23-055717#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2915.0,"shares_display":"2,915","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":87450.0,"total_display":"87,450.00","total_whole":"87,450","shares_owned_after":1764.0,"shares_owned_after_display":"1,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":9213172,"accession":"0000950170-25-091759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-091759","line_url":"/filing/0000950170-25-091759#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1752.0,"shares_display":"1,752","price_per_share":14.24,"price_display":"14.24","price_state":"stated","total_value":24948.48,"total_display":"24,948.48","total_whole":"24,948","shares_owned_after":3294.0,"shares_owned_after_display":"3,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-29","filed_date":"2025-06-30","scope":"insider"},{"id":6340998,"accession":"0000899243-22-000180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-000180","line_url":"/filing/0000899243-22-000180#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1764.0,"shares_display":"1,764","price_per_share":14.23,"price_display":"14.23","price_state":"stated","total_value":25101.72,"total_display":"25,101.72","total_whole":"25,102","shares_owned_after":1764.0,"shares_owned_after_display":"1,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-29","filed_date":"2022-01-03","scope":"insider"},{"id":9213171,"accession":"0000950170-25-091756","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-091756","line_url":"/filing/0000950170-25-091756","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2338.0,"shares_display":"2,338","price_per_share":12.843421727972625,"price_display":"12.84","price_state":"stated","total_value":30027.92,"total_display":"30,027.92","total_whole":"30,028","shares_owned_after":2687.0,"shares_owned_after_display":"2,687","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2025-06-30","scope":"insider","n_lines":2},{"id":2767296,"accession":"0000950170-24-014523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-014523","line_url":"/filing/0000950170-24-014523","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3433.0,"shares_display":"3,433","price_per_share":12.955415088843576,"price_display":"12.96","price_state":"stated","total_value":44475.94,"total_display":"44,475.94","total_whole":"44,476","shares_owned_after":1891.0,"shares_owned_after_display":"1,891","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2024-02-13","scope":"insider","n_lines":2},{"id":2586314,"accession":"0000950170-24-014537","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-014537","line_url":"/filing/0000950170-24-014537","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001855608","owner_name":"Valantine Hannah","owner_display_name":"Valantine Hannah","owner_url":"/insider/0001855608","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3433.0,"shares_display":"3,433","price_per_share":12.955415088843576,"price_display":"12.96","price_state":"stated","total_value":44475.94,"total_display":"44,475.94","total_whole":"44,476","shares_owned_after":1891.0,"shares_owned_after_display":"1,891","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2024-02-13","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001217234","name":"CareDx, Inc.","url":"/issuer/0001217234","role":"Director","n_filings":3,"first_seen":"2025-06-23","last_seen":"2026-07-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001743881","name":"BridgeBio Pharma, Inc.","url":"/issuer/0001743881","role":"Director","n_filings":16,"first_seen":"2022-01-03","last_seen":"2026-06-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001855608","retrieved_at":"2026-08-26T17:20:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}